In keeping with the frequent alterations of chromosome 9p24.1 and PD-L1/PD-L2 expression seen in certain NHL subtypes, PMBCL, PCNSL, and PTL studies have shown more favorable responses to PD-1 blockade. The gene discussed is CD274; the disease is non-Hodgkin lymphoma.